The results of this study could inform the future development of a follow-up protocol utilizing 68Ga-PSMA PET-CT imaging to enhance the detection of local recurrences and metastatic disease, as well as monitor long-term survival outcomes in prostate cancer patients. This evidence concerns the gene FOLH1 and Familial prostate cancer.